Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 23 Issue 6
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2005  >  (6): 348-350

Chen An-qing, Wang Zhe, Wang Chun-sheng, Zhao Qiang, Xu De-min. The clinical use of fibrin sealant in cardiovascular surgery[J]. Journal of Pharmaceutical Practice and Service, 2005, (6): 348-350.
Citation: Chen An-qing, Wang Zhe, Wang Chun-sheng, Zhao Qiang, Xu De-min. The clinical use of fibrin sealant in cardiovascular surgery[J]. Journal of Pharmaceutical Practice and Service, 2005, (6): 348-350.
shu

The clinical use of fibrin sealant in cardiovascular surgery

  • Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China

  • Received Date: 2005-10-15
  • Objective To assess the hemostatic effect and security of fibrin sealant in cardiovascular surgery. Methods 60 patients who were performed open-heart operations with incisions on aorta or right ventricle were divided randomly into test group or control group. Each group contains 30 patients. FS(test group) or NS(control group) were local used on the incisions in these patients. The hemostatic time and bleeding quantity were used as main evaluating indicators. 7 patients of test group underwent 3 months followup for the security. Results The hemostatic time(14.67±6.18s) and bleeding quantity(0.81±0.54g) of test group were obviously better than control group(250.45±37.02s and 15.39±2.69g). Conclusion Fibrin sealant has good effects of hemostasis and tissue conglutination in cardiovascular surgery.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(1898) PDF downloads(572) Cited by()

Related
Proportional views

The clinical use of fibrin sealant in cardiovascular surgery

  • Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China
  • Received Date: 2005-10-15

Abstract: Objective To assess the hemostatic effect and security of fibrin sealant in cardiovascular surgery. Methods 60 patients who were performed open-heart operations with incisions on aorta or right ventricle were divided randomly into test group or control group. Each group contains 30 patients. FS(test group) or NS(control group) were local used on the incisions in these patients. The hemostatic time and bleeding quantity were used as main evaluating indicators. 7 patients of test group underwent 3 months followup for the security. Results The hemostatic time(14.67±6.18s) and bleeding quantity(0.81±0.54g) of test group were obviously better than control group(250.45±37.02s and 15.39±2.69g). Conclusion Fibrin sealant has good effects of hemostasis and tissue conglutination in cardiovascular surgery.

Chen An-qing, Wang Zhe, Wang Chun-sheng, Zhao Qiang, Xu De-min. The clinical use of fibrin sealant in cardiovascular surgery[J]. Journal of Pharmaceutical Practice and Service, 2005, (6): 348-350.
Citation: Chen An-qing, Wang Zhe, Wang Chun-sheng, Zhao Qiang, Xu De-min. The clinical use of fibrin sealant in cardiovascular surgery[J]. Journal of Pharmaceutical Practice and Service, 2005, (6): 348-350.
shu

    HTML

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return